Avantor, Inc. to Post Q3 2024 Earnings of $0.26 Per Share, William Blair Forecasts (NYSE:AVTR)

Avantor, Inc. (NYSE:AVTR) – Equities research analysts at William Blair cut their Q3 2024 earnings per share estimates for shares of Avantor in a report released on Monday, April 29th. William Blair analyst M. Larew now anticipates that the company will earn $0.26 per share for the quarter, down from their prior forecast of $0.27. The consensus estimate for Avantor’s current full-year earnings is $1.01 per share. William Blair also issued estimates for Avantor’s Q1 2025 earnings at $0.28 EPS, Q3 2025 earnings at $0.33 EPS, Q4 2025 earnings at $0.38 EPS and FY2025 earnings at $1.28 EPS.

AVTR has been the subject of several other reports. Robert W. Baird reduced their price objective on Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research note on Monday. Evercore ISI raised their price objective on Avantor from $26.00 to $28.00 and gave the stock an “outperform” rating in a research report on Thursday, April 4th. Barclays boosted their price objective on shares of Avantor from $27.00 to $30.00 and gave the company an “overweight” rating in a research report on Wednesday, April 10th. JPMorgan Chase & Co. lifted their price objective on Avantor from $26.00 to $29.00 and gave the company an “overweight” rating in a research report on Thursday, February 15th. Finally, UBS Group raised their price objective on shares of Avantor from $25.00 to $29.00 and gave the company a “buy” rating in a research report on Thursday, February 15th. Four analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $26.71.

Avantor Price Performance

NYSE:AVTR opened at $24.42 on Tuesday. Avantor has a 52-week low of $16.63 and a 52-week high of $26.16. The company has a quick ratio of 1.05, a current ratio of 1.61 and a debt-to-equity ratio of 0.94. The firm has a market cap of $16.58 billion, a P/E ratio of 62.60, a PEG ratio of 1.47 and a beta of 1.37. The business’s 50-day moving average price is $25.09 and its 200 day moving average price is $22.69.

Avantor (NYSE:AVTR) last posted its quarterly earnings data on Friday, April 26th. The company reported $0.22 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.02. The business had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.68 billion. Avantor had a net margin of 3.79% and a return on equity of 13.01%. The company’s quarterly revenue was down 5.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.29 earnings per share.

Insider Transactions at Avantor

In related news, EVP James Bramwell sold 6,203 shares of the stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $24.49, for a total value of $151,911.47. Following the sale, the executive vice president now owns 101,143 shares in the company, valued at approximately $2,476,992.07. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.30% of the stock is owned by company insiders.

Institutional Trading of Avantor

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Raymond James & Associates raised its stake in Avantor by 84.8% during the fourth quarter. Raymond James & Associates now owns 1,165,646 shares of the company’s stock worth $26,612,000 after acquiring an additional 534,901 shares in the last quarter. Federated Hermes Inc. boosted its holdings in shares of Avantor by 19.9% during the 4th quarter. Federated Hermes Inc. now owns 628,189 shares of the company’s stock worth $14,342,000 after buying an additional 104,296 shares in the last quarter. DAVENPORT & Co LLC lifted its position in shares of Avantor by 17.6% during the 4th quarter. DAVENPORT & Co LLC now owns 2,283,767 shares of the company’s stock valued at $52,430,000 after acquiring an additional 342,452 shares during the period. Vaughan Nelson Investment Management L.P. boosted its position in shares of Avantor by 8.4% during the 4th quarter. Vaughan Nelson Investment Management L.P. now owns 2,508,557 shares of the company’s stock worth $57,269,000 after purchasing an additional 194,031 shares in the last quarter. Finally, Northern Trust Corp boosted its holdings in Avantor by 9.0% in the third quarter. Northern Trust Corp now owns 4,129,447 shares of the company’s stock worth $87,049,000 after acquiring an additional 342,553 shares in the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.